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bstract
Rattan tea, made from the leaves of Ampelopsis  grossedentata, may potentially perform multiple pharmacological roles, including anti-bacterial,
nti-cancer, antioxidant, hepatoprotective and anti-hypertension functions. These beneficial functions of Rattan tea are strongly associated with
he bioactivity of ampelopsin, a major flavonoid compound in Rattan tea. In this review, we summarize current research related to the bioactivity
nd pharmacological mechanisms of ampelopsin, which will provide a better reference for its potential application in the prevention of chronic
iseases.
 2012 Production and hosting by Elsevier B.V. on behalf of Beijing Academy of Food Sciences.
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.  Introduction
Rattan tea is a traditional Chinese herbal remedy prepared
rom the stems and leaves of the plant Ampelopsis  grossedentata.
mpelopsin is one of the most important flavonoids found in
attan tea. As a dihydromyricetin (DMY), ampelopsin was first
solated from Ampelopsis  meliaefolia  by Kotake and Kubota in
940, and was later reported as a major bioactive component in
mpelopsis grossedentata  [1]. Today, ampelopsin from Rattan
ea is known for a broad range of biological functions including
ypoglycemic [2], antioxidant [3,4], anti-inflammatory [5], anti-
umor [6–8], hepatoprotective [4,9], and neuroprotective effects
10].
Because of these reported effects, research into the bioactivity
f ampelopsin in Rattan tea has gained increasing attention over
he last decade, leading to increased understanding of its pharma-
ological functions and underlying mechanisms. In this review,
e summarize current research related to the pharmacological∗ Corresponding author at: The Cancer Institute of New Jersey, 195 Little
lbany Street, New Brunswick, NJ 08903, USA.
E-mail address: nchen510@gmail.com (N. Chen).
eer review under responsibility of Beijing Academy of Food Sciences.
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eijing Academy of Food Sciences.
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unctions and corresponding action mechanisms, as well as
otential human health benefits of ampelopsin.
. Anti-bacterial  and  anti-inﬂammatory  effects
Ampelopsin in crude plant extracts has been applied to alle-
iate inflammatory diseases as a broad-spectrum anti-bacterial
rug for several centuries. The ampelopsin extract exerts strong
nhibitory effects on Staphylococcus  aureus  and Bacillus  sub-
ilis. In addition, ampelopsin is also sensitive to inhibit other
athogenic microorganisms such as Aspergillus  flavus, penicil-
ium and transport streptavidin [11]. Additionally, ampelopsin
an inhibit acute or sub-acute inflammation such as croton oil-
nduced auricular edema or formaldehyde-induced paw edema
n mice, and carrageenan-induced paw edema in rats, as well as
bdominal capillary permeability [12]. Similarly, ampelopsin
solated from Salix  sachalinensis  also has a strong inhibitory
ffect on Cladosporium  herbarum  [13]. A structure–activity
elationship analysis has indicated that the hydroxyl groups at 5
ositions (i.e., 5, 7, 3′, 4′ and 5′) can significantly enhance the
nti-inflammatory activity of ampelopsin.
Inflammatory cytokines such as interleukin-1 beta (IL-1)
nd tumor necrosis factors (TNF-) can up-regulate the pro-
uction of nitric oxide (NO) and prostaglandin E2 (PGE2),
hus stimulating the expression or activity of inducible NO
ynthase (iNOS), cyclooxygenase-2 (COX-2) and microsomal
GE synthase-1 (mPGES-1) in target cells. Ampelopsin has
een reported to inhibit NO production in lipopolysaccha-
ide (LPS)-stimulated RAW264.7 macrophages and reduce
arrageenan-induced acute inflammation in  vivo  [14], which is
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onsistent with another report that ampelopsin plays an impor-
ant role not only in reducing the production of pro-inflammatory
ediators such as IL-1, IL-6 and TNF-, but also in inhibi-
ing the activity of iNOS. Moreover, ampelopsin can selectively
nhibit the production of iNOS in LPS-stimulated macrophages
nd RAW264.7 cells by suppressing the mRNA and protein
xpression of iNOS.
Nuclear factor-kappaB (NF-B), as a sensitive transcription
actor for regulating the genes responsible for both innate and
daptive immune response, has been identified as a major factor
nvolved in the regulation of pro-inflammatory cytokines such
s iNOS and COX-2 [15]. Usually NF-B resides in the cyto-
lasm associated with its inhibitor (I-B). Once the inhibitor
s released, NF-B can be phosphorylated and then translo-
ated to the nuclei. The inhibitory effect of ampelopsin on the
nduction and expression of iNOS is partially mediated through
nhibiting NF-B activity and reducing the expression of the
65 subunit of NF-B in RAW264.7 cells under stimulation by
PS [5]. MAPKs and PI3K/Akt are involved in the induction
f pro-inflammatory genes in activated macrophages [16,17].
owever, ampelopsin can exert significant inhibition of the
I3K/Akt signaling pathway without altering the activation of
AP kinases. Moreover, PI3K may act as an upstream regulator
f IKK/NF-B activation, and ampelopsin can inhibit NF-B-
egulated pro-inflammatory gene expression by blocking the
I3K/Akt/NF-B signaling cascades.
Another contributor to cellular damage during inflamma-
ion is oxidative stress [18]. The administration of ampelopsin
an significantly inhibit LPS-induced intracellular ROS levels.
n the other hand, as an inhibitor of ROS, N-acetyl-cysteine
NAC) can greatly suppress the phosphorylation of Akt and IKK
s well as the downstream I-B. The reported association of
mpelopsin with these pathways further confirms the potential
nti-inflammatory activity of ampelopsin.
. Anti-tumor  activity
Currently, much attention has been paid to the anti-tumor
ctivity of ampelopsin in cell and animal studies [7,8]. The
nti-metastatic effect of ampelopsin on melanoma and prostate
ancer has been confirmed via  in  vivo  and in  vitro  studies
6,19,20]. In addition, reports suggest that ampelopsin may
uppress angiogenesis by inhibiting the secretion of vascu-
ar endothelial growth factor (VEGF) and basic fibroblast
rowth factor (bFGF) from human hepatocellular carcinoma
ells in  vitro. A similar strong inhibitory effect on the growth of
uman hepatocellular carcinoma in mice has also been reported
21]. These reports indicate that ampelopsin exerts its anti-tumor
ffects by modulating multiple signaling pathways, including
poptosis, cell cycle arrest, cell growth inhibition and metastatic
nhibition at various cellular levels.
.1. Regulation  of  proliferation  and  cell  cycle  arrestAmpelopsin-containing serum can inhibit the proliferation
f B16 cells by interrupting DNA synthesis [22]. Similarly,
mpelopsin produces an obvious inhibition on the proliferation
m
B
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f Bel-7402, HL-60, and K562 cells in a dose-dependent man-
er [23]. Interestingly, ampelopsin can also inhibit the growth
f H22 cells with IC50 of 18.65 g/mL, but the inhibitory rate is
egatively correlated with ampelopsin. Moreover, ampelopsin
lso exhibits anti-tumor effect on bladder cancer in orthotopic
enograft models, which is mediated by cell cycle arrest [24].
Previous studies have demonstrated cancer specific pharma-
ological activity of ampelopsin resulting in growth inhibition
f androgen-sensitive (LNCaP) and androgen-insensitive (PC-3)
uman prostate cancer cell lines in  vitro. These anti-proliferative
ffects, which are not observed in normal prostate epithelial
ells even at higher doses [6], are mediated by down-regulating
yclin-dependent kinase (CDK2) in LNCaP cells and cell cycle
 (CDC2) protein levels in PC-3 cells [6]. Since CDC2 is con-
idered an essential molecular target for designing anti-cancer
rugs [25], ampelopsin should be a promising molecule for the
evelopment of anti-cancer drugs.
.2. Inhibition  of  apoptosis
The capacity to induce apoptosis in tumor cells is a pri-
ary pharmacological mechanism of certain anti-tumor drugs
26,27]. The overloading of calcium ions can result in the
pening of mitochondrial permeability transition pores, thereby
nducing changes in osmotic pressure, ATP depletion and mito-
hondrial shrinkage, and finally apoptosis [28]. Lung cancer is
 serious threat to human health and ampelopsin can induce the
poptosis of lung adenocarcinoma cell line AGZY-83-a cells
y promoting the increase in intracellular calcium levels and
aspase-3 activity [29], although the mechanism associated with
his has not yet been determined.
Ampelopsin also induces apoptosis in prostate cancer mainly
hrough down-regulation of Bcl-2, an important regulator of
poptosis that exhibits increased expression in both metastatic
nd non-metastatic tumors [30,31]. Furthermore, ampelopsin in
he concentration range of 2.2-14.84 mg/L can exert inhibitory
ffects on the growth of gastric cancer cell line SGC-7901.
he chemotherapeutic drug mitomycin (MMC), when combined
ith ampelopsin, produces an obvious synergistic inhibition on
he growth of SGC-7901 cells, which is also correlated with
he inhibitory expression of apoptotic proteins such as Bcl-2
nd survivin [32]. Therefore, the down-regulation of Bcl-2 can
e an important molecular mechanism of ampelopsin-induced
poptosis. The application of anti-cancer drugs combined
ith ampelopsin will be a novel therapeutic strategy for
ancers.
.3. Inhibition  of  invasion  and  migration
Metastasis is the major cause of death associated with can-
er, and many factors can affect the invasion and metastasis of
ancers. Ampelopsin can significantly attenuate the metastatic
rocess of cancers by inhibiting the degradation of the base-
ent membrane. Ampelopsin can also inhibit the adhesion of
16 mouse melanoma cells to fibronectin, lamin, or matrigel,
hus attenuating invasion into the reconstituted basement mem-
rane as demonstrated by in  vitro  experiments [19,20]. Matrix
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etalloproteinases (MMPs), a family of secreted or membrane-
ssociated proteins capable of digesting extracellular matrix
omponents, are thought to play an essential role in can-
er metastasis [33]. Moreover, the up-regulation of MMP-2/-9
xpression is the critical step of invasion and metastasis of can-
er cells. Ampelopsin can inhibit the invasion of human breast
ancer (MDA-MB-231) cells in a dose-dependent manner, and
he mechanism associated with this may involve down-regulated
xpression of MMP-2/-9 in both the extracellular matrix and the
ntracellular space [34]. Additionally, ampelopsin may inhibit
he expression of CXCR4, a protein associated with prostate can-
er, resulting in inhibition of invasion and migration of prostate
ancer cells [6].
Adriamycin (ADM) is a potent anti-tumor agent in clini-
al cancer treatments. Unfortunately, the application of ADM
s limited due to its cytotoxicity to skeletal muscle, heart
nd liver. In 4T1 breast cancer cells, the combination of
mpelopsin and ADM can inhibit tumor growth in S180- and
T1-transplanted mice. Ampelopsin apparently sensitizes the
nti-tumor efficacy of ADM, and attenuates ADM-induced tox-
city in heart and liver [35,36]. All of these investigations
urther confirm the anti-invasion potential of ampelopsin during
ancer treatments. In addition, ampelopsin can increases intra-
ellular accumulation of chemotherapeutic drugs in multi-drug
esistance (MDR)-associated tumor cells, and correspondingly
educes the cytotoxicity of chemotherapeutic drugs by inhibiting
he efflux of drugs via  permeability glycoprotein (P-gp), which
uggests ampelopsin may also be a promising MDR modulator
37].
. Hepatoprotective  function
Ampelopsin F and G isolated from Ampelopsis  brevipedun-
ulata Var. hancei can suppress carbon tetrachloride- (CCl4)
r galactosamine-induced liver injury in rats. Ampelopsin E
nd cis-ampelopsin E exert an obvious inhibitory effect on
epatitis virus [38]. In galactosamine, d-galactosamine and
lpha-naphthylisothiocyanate (ANIT) induced acute liver injury
odels, the administration of ampelopsin can inhibit the activity
f serum transaminases such as alanine aminotransferase (ALT)
nd aspartate aminotransferase (AST), and alleviate patho-
ogical damage of liver tissues. Ampelopsin can also reduce
he production of malondialdehyde (MDA) in CCl4-induced
iver injury, and increase superoxide dismutase (SOD) activity
39]. A diet containing ethanolic extract (1%) or ampelopsin
0.1%) can significantly suppress the increase of serum lac-
ate dehydrogenase (LDH), ALT, AST and -tocopherol levels
n rats with d-galactosamine-induced liver injury [4]. In addi-
ion, ampelopsin also has a protective effect against CCl4,
-galactosamine and LPS-induced liver cell damage in mice [9].
mpelopsin mainly inhibits the collagen formation of hepatic cells. Following hepatic M cell transplantation in cultured
at liver tissues, collagen fibers are easily produced. However,
mpelopsin can inhibit the formation of new collagen fibers,
nd further disperse old collagen fibers into small micro-blocks
o
d
t
auman Wellness 1 (2012) 14–18
40]. The hepatoprotective function of ampelopsin may therefore
rovide a promising therapeutic strategy for hepatitis B [41].
. Anti-hypertension  effect
In animal experiments, ampelopsin has been shown to antag-
nize norepinephrine (NE) and high K+-induced contraction of
abbit aorta, suggesting that ampelopsin can play a blockage
ole in intestinal smooth muscle and aortic -receptor [42]. Fur-
her studies have confirmed that ampelopsin can significantly
nhibit the contractions associated with Ca2+ release caused by
E [43]. However, ampelopsin inhibitory effects on extracel-
ular Ca2+ release are observed only at higher concentrations.
hese findings suggest that ampelopsin may function as an anti-
ypertension drug by selectively blocking voltage-dependent
alcium channels (PDC).
. Regulation  of  plasma  lipids  and  blood  glucose
An anti-atherosclerotic effect of ampelopsin has also been
eported. The intragastric administration of Ampelsis  grosseden-
ata reduces the levels of serum total cholesterol (TC) and
riglyceride (TG), and increases serum high-density lipoprotein
holesterol (HDL-C) levels in rats, indicating a hypocholes-
erolemic effect of ampelopsin. In accordance with these
ndings, a drink containing Ampelsis  grossedentata  at a dose
f 9 g/day was administered to 100 patients with primary hyper-
ipidemia, resulting in quantifiable reductions in TC, TG and
lasma lipid by 42%, 72% and 28% after 45 days administration,
espectively. In addition, ampelopsin can significantly increase
he content of serum SOD, and reduce the content of MDA
44], therefore, ampelopsin can prevent the invasion of vascular
mooth muscle cells and matrix degradation, which correspond-
ngly contributes to protective effects against atherosclerosis and
ancer.
During the investigation into the relationship between green
ea and obesity-related insulin resistance syndrome, green tea
as found to enhance insulin activity in  vitro  and reduce
ypertriacylglycerolemia in mice [45–48]. Currently, effec-
ive drugs for treating diabetes, metformin and glibenclamide,
ave been found to produce side effects during clinical use.
libenclamide has been found to significantly reduce blood
lucose in normal mice [49]. Conversely, ampelopsin has no
mpact on blood glucose in normal mice, but can reduce blood
lucose levels in alloxan-induced diabetic or hyperglycemic
ice.
Additionally, in d-galactose-induced impaired glucose toler-
nce (IGT) animal models, intragastric injection of ampelopsin
an significantly reduce the concentration of fasting blood
lucose, 2 h postprandial blood glucose and insulin levels.
his suggests a possible therapeutic role in the treatment of
iabetes, which is characterized by the inability of insulin
o inhibit the production of hepatic glucose [50]. More-
ver, ampelopsin exerts a protective effect on early renal
amage by inhibiting the content of microalbuminuria and
he activity of LDH in kidney. These findings suggest that
mpelopsin can effectively improve the health status of IGT
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ats and provide a protective function against early kidney dam-
ge.
. Neuroprotective  effect
Oxidative stress is believed to be a primary factor in neu-
odegenerative diseases, such as Alzheimer’s disease (AD),
arkinson’s disease and Huntington’s disease, as well as
myotrophic lateral sclerosis [51,52]. ROS-associated with
xidative stress can induce cell apoptosis through mito-
hondrial dysfunction and damage to lipids, proteins and
NA [53,54]. Therefore, antioxidants have gained tremen-
ous attention as promising therapeutics for neurodegenerative
iseases. Rattan tea is a popular beverage worldwide, espe-
ially in China and other Asian countries. Ampelopsin in
attan tea is an antioxidant flavonoid that can enhance cel-
ular antioxidant defenses through activation of ERK and
kt signaling pathways, induce heme oxygenase-1 (HO-1)
xpression and protect PC12 cells from H2O2-induced apo-
tosis [10]. In sodium pentobarbital-induced mouse hypnosis
xperiments, ampelopsin can significantly extend the incu-
ation period caused by sodium pentobarbital, reduce the
ength of time associated with hypnotic effects and signifi-
antly reduce ethanol-induced inebriation reaction [55]. This
echanism may be associated with increased activity of liver
icrosomal enzyme and accelerated metabolism of alcohol or
odium pentobarbital. Therefore, ampelopsin may also have a
ovel function as a neuroprotectant in neurodegenerative condi-
ions.
. Antioxidant  effect
ROS is implicated in many pathogenic processes including
nflammation and cancer. Detoxification of ROS by antioxi-
ants provides a measure of protection against these diseases,
herefore natural plant components, especially antioxidants, are
f great interest. Ampelopsin possesses excellent antioxidant
ctivity due to its similarity with tertiary butylhydroquinone
TBHQ) [56]. It is well known that free radicals can induce lipid
xidation in biomembranes, and damage of the cell membrane
s the basis for tissue damage and for the pathological processes
f many diseases. Similarly, exogenous damage is also strongly
orrelated with free radical reactions. Ampelopsin has previ-
usly demonstrated a strong inhibitory effect on H2O2-induced
xidative damage in cell-free systems including red blood cells
nd in  vitro  cell cultures [57]. This is due to the scavenging
f free radicals by ampelopsin, which reduces radical-induced
ipid peroxidation of cell membranes and inhibits MDA gener-
tion. Similarly, ampelopsin has been reported to significantly
nhibit superoxide anion radical activity and lipid peroxidation
f liver homogenate and mitochondria during stimulation
f auto-oxidation and induced-oxidation, and the inhibitory
ffect of ampelopsin on free radicals and lipid peroxidation is
oncentration-dependent [3,58]. Therefore, ampelopsin exhibits
avorable antioxidant activity that may mitigate cellular oxida-
ive stress and stimulate the potential of cellular vitality, thus
[uman Wellness 1 (2012) 14–18 17
ccomplishing the prevention of neurodegenerative diseases,
ardiovascular diseases, cancer and other diseases.
. Conclusion
Naturally occurring substances derived from diets or dietary
upplements such as Rattan tea provide a new approach for
he prevention or therapeutic treatment of chronic diseases.
mpelopsin, as the predominant compound in Rattan tea, pos-
esses potent anti-inflammatory activity whereby it can inhibit
he activation of NF-B and PI3K/Akt pathways, and inhibit
xidative stress by scavenging free radicals and attenuating
ipid oxidation as well as reducing ROS levels. Furthermore,
mpelopsin appears to both reduce the risk of cancer and regulate
lood glucose and lipids, although the underlying mechanisms
ssociated with the capabilities remain to be further explored.
uture in  vitro  experimental studies and in  vivo  clinical studies
hould focus on not only the understanding these mechanisms,
ut also the development of ampelopsin as a chemopreventive
gent to treat a wide range of diseases.
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